Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SPINK1: a new therapeutic target in cancer?

Literature DB >> 21878561

SPINK1: a new therapeutic target in cancer?

Ulf-Håkan Stenman¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2011 PMID： 21878561 DOI： 10.1373/clinchem.2011.168476

Source DB: PubMed Journal: Clin Chem ISSN： 0009-9147 Impact factor: 8.327

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.

Authors: Yi-Ting Chen; Shu-Chuan Tsao; Shyng-Shiou F Yuan; Hung-Pei Tsai; Chee-Yin Chai
Journal: Pathol Oncol Res Date: 2015-06-03 Impact factor: 3.201

Review 2. Emerging biomarkers of prostate cancer (Review).

Authors: Sarah K Martin; Taylor B Vaughan; Timothy Atkinson; Haining Zhu; Natasha Kyprianou
Journal: Oncol Rep Date: 2012-05-25 Impact factor: 3.906

Review 3. Molecular signatures in urologic tumors.

Authors: Spencer Larkin; Natasha Kyprianou
Journal: Int J Mol Sci Date: 2013-09-06 Impact factor: 5.923

4. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.

Authors: Christine Mehner; Ann L Oberg; Kimberly R Kalli; Aziza Nassar; Alexandra Hockla; Devon Pendlebury; Magdalena A Cichon; Krista M Goergen; Matthew J Maurer; Ellen L Goode; Gary L Keeney; Aminah Jatoi; Miklós Sahin-Tóth; John A Copland; Derek C Radisky; Evette S Radisky
Journal: Oncotarget Date: 2015-11-03

5. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.

Authors: Constantin Georgescu; Joshua M Corbin; Sandra Thibivilliers; Zachary D Webb; Yan D Zhao; Jan Koster; Kar-Ming Fung; Adam S Asch; Jonathan D Wren; Maria J Ruiz-Echevarría
Journal: BMC Cancer Date: 2019-05-06 Impact factor: 4.430

6. Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine.

Authors: Yi-Ting Chen; Tzu-Ting Tseng; Hung-Pei Tsai; Shih-Hsun Kuo; Ming-Yii Huang; Jaw-Yuan Wang; Chee-Yin Chai
Journal: Hum Cell Date: 2022-09-02 Impact factor: 4.374